What does purple striae look like in a 40-year-old white female patient taking estradiol (estrogen replacement therapy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Appearance of Purple Striae

Purple striae appear as violaceous (purple-red) linear bands on the skin, typically wide (>1 cm), with a characteristic distribution on the abdomen, thighs, breasts, and axillae, representing a highly specific clinical feature of hypercortisolism that should immediately prompt evaluation for Cushing syndrome. 1

Visual Characteristics

Unfortunately, I cannot provide photographs as none were included in the available medical literature. However, the clinical description is well-established:

  • Color progression: Striae begin as erythematous (red) lesions called striae rubra, which appear violaceous or purple-red in lighter skin tones 2, 3
  • Erythema index: Striae rubra demonstrate significantly higher erythema index measurements compared to striae alba (older, white stretch marks) and normal skin 3
  • Skin brightness: Purple/red striae have significantly lower brightness values than both white striae and normal skin 3
  • Width: In pathologic conditions like Cushing syndrome, striae are characteristically wide (>1 cm) 1
  • Surface texture: The affected skin shows increased roughness compared to normal skin, with decreased elasticity and lower dermal echo-density 3

Anatomic Distribution Patterns

In Cushing syndrome specifically, purple striae appear in characteristic locations: 1

  • Abdomen (most common)
  • Thighs
  • Breasts
  • Axillae
  • Supraclavicular region

Critical Diagnostic Context for Your Patient

In a 40-year-old woman on estrogen replacement therapy, purple striae are NOT typically caused by estradiol alone and should raise immediate concern for Cushing syndrome or exogenous corticosteroid exposure. 1 The key diagnostic considerations include:

Immediate Evaluation Required

  • Exclude iatrogenic Cushing syndrome first: Review all medications for corticosteroid exposure, including inhaled/intranasal preparations, topical steroids, or systemic glucocorticoids 1
  • Screen for endogenous hypercortisolism if no exogenous steroids identified, using one of: 24-hour urinary free cortisol (>4× normal strongly suggests Cushing), late-night salivary cortisol, or 1 mg overnight dexamethasone suppression test 1

Associated Clinical Features to Assess

Look specifically for: 1

  • Centripetal obesity with supraclavicular fat pad and buffalo hump
  • Proximal muscle weakness (difficulty rising from chair without using arms)
  • Facial plethora and moon facies
  • Hypertension and hyperglycemia
  • Psychiatric disturbances or mood changes

Important Clinical Pitfall

Estrogen replacement therapy does NOT cause purple striae. 4 While striae distensae are associated with hormonal changes during pregnancy and puberty, therapeutic estradiol doses used in hormone replacement therapy do not produce the wide, purple striae characteristic of hypercortisolism 4. The presence of purple striae in your patient warrants investigation for an alternative etiology, particularly Cushing syndrome or undisclosed corticosteroid use.

References

Guideline

Differential Diagnosis for Purple Striae

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Biophysical properties of striae rubra and striae alba in human skin: Comparison with normal skin.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.